Laurion Capital Management »

Abeona Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.3M 1.3M 6.32
2024-06-30 $6.4M 1.5M 4.24
2024-03-31 $4.7M 647k 7.25

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding Abeona Therapeutics

Nantahala Capital Management
Suvretta Capital Management
Vanguard Group
Rosalind Advisors
Western Standard
Laurion Capital Management
Propel Bio Management
683 Capital Management
Citigroup
Morgan Stanley
Ikarian Capital
BlackRock
Geode Capital Management
BlackRock
Simplify Asset Management

View all funds holding Abeona Therapeutics